The Patent Finder

Targimmune Therapeutics AG

Also on record
Records under this name other than the patents Targimmune Therapeutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 3 of 3 · Back to Targimmune Therapeutics AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,230,580Chimeric proteins for targeting dsRNA
Formerly held
Lapsed on the fee record
Ended Jan 25, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 25, 2026USPTO record
US 7,927,792Targeted double stranded RNA mediated cell killing
Term ended
Term ended Mar 26, 2024 · USPTO record
Term endedTerm ended Mar 26, 2024USPTO record
US 8,372,818Targeted double stranded RNA mediated cell killing
Term ended
Ended no later than Nov 12, 2023 · USPTO record
Term endedEnded no later than Nov 12, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited